The draft Order published at the official website of the Federal Customs Service (FCS) announces reduction of the number of customs posts eligible for clearing the pharmaceuticals (from 20 to 4 posts).
In particular, it is intended to keep operating: the Lytkarinsky post (the warehouse of “Items-Warehouses” logistics provider), the Davydovsky post (“Farmat”), the Department for customs clearance and customs control # 2 of the Davydovsky customs post (“Norston”) and the Mamontovsky post (“The customs warehouse TransService” owned by Protek Group).
The five-fold cut-down of customs posts might result in disruptions in drugs supplies.
The FCS Order is currently under review of the Ministry of Justice and, if approved, it will be registered and enforced within 30 days after publishing in "Rossiyskaya Gazeta". As per the FCS, practically the number of customs posts is going to be cut in May.
The law is aimed at improving the activities of the federal, regional and local state authorities with respect to placing orders for supply of goods, works and services for state and municipal needs, ensuring the publicity and transparency of orders placement, preventing corruption and other abuses.
The Russian Government was also requested to present suggestions for improving the existent methodology for determining the maximum manufacturers’ prices for essential drugs. The Prime Minister of Russia Vladimir Putin was assigned to be responsible in this respect.
In addition, the President instructed the Minister of Health and Social Development of Russia Tatiana Golikova to issue by June 1, 2011 the normative acts specifying the requirements to the content and completion of the documents required for compiling a pharmaceutical dossier.
According to the Prime Minister, it is planned to invest 120 billion Rubles into developing the pharmaceutical sector by 2020. The respective expenditures are presumed by the Federal program for development of the pharmaceutical industry until 2020.